Heteroaryl derivatives
    1.
    发明授权
    Heteroaryl derivatives 失效
    杂芳基衍生物

    公开(公告)号:US08217031B2

    公开(公告)日:2012-07-10

    申请号:US12593566

    申请日:2008-03-28

    IPC分类号: A61K31/55 C07D223/16

    CPC分类号: C07D491/048 C07D495/04

    摘要: The present invention relates to a compound represented by formula [1] or a pharmaceutically acceptable salt thereof: In formula [1], one of X and Y is CH and the other is oxygen or sulfur; R is hydrogen, etc.; Z is hydrogen, etc.; Ar is phenyl, etc.; and n is 1 or 2 and or m is 1 or 2, excluding compounds where n is 2 and m is 2 simultaneously. Also provided is a pharmaceutical composition comprising a compound of formula [1] or a pharmaceutically acceptable salt thereof as an active ingredient. The composition is usable as an agent for the prevention or treatment of depression, panic disorder, anxiety, obsessive-compulsive disorder, chronic pain, fibromyalgia, obesity, stress urinary incontinence, and overactive bladder.

    摘要翻译: 本发明涉及由式[1]表示的化合物或其药学上可接受的盐:在式[1]中,X和Y之一是CH,另一个是氧或硫; R是氢等; Z是氢等; Ar是苯基等; n为1或2,m为1或2,不包括n为2,m为2的化合物。 还提供了包含式[1]化合物或其药学上可接受的盐作为活性成分的药物组合物。 该组合物可用作预防或治疗抑郁症,恐慌症,焦虑症,强迫症,慢性疼痛,纤维肌痛,肥胖,压力性尿失禁和膀胱过动症的药剂。

    HETEROARYL DERIVATIVES
    2.
    发明申请
    HETEROARYL DERIVATIVES 失效
    HETEROARYL衍生物

    公开(公告)号:US20100048537A1

    公开(公告)日:2010-02-25

    申请号:US12593566

    申请日:2008-03-28

    CPC分类号: C07D491/048 C07D495/04

    摘要: The present invention relates to a compound represented by formula [1] or a pharmaceutically acceptable salt thereof: In formula [1], one of X and Y is CH and the other is oxygen or sulfur; R is hydrogen, etc.; Z is hydrogen, etc.; Ar is phenyl, etc.; and n is 1 or 2 and or m is 1 or 2, excluding compounds where n is 2 and m is 2 simultaneously. Also provided is a pharmaceutical composition comprising a compound of formula [1] or a pharmaceutically acceptable salt thereof as an active ingredient. The composition is usable as an agent for the prevention or treatment of depression, panic disorder, anxiety, obsessive-compulsive disorder, chronic pain, fibromyalgia, obesity, stress urinary incontinence, and overactive bladder.

    摘要翻译: 本发明涉及由式[1]表示的化合物或其药学上可接受的盐:在式[1]中,X和Y之一是CH,另一个是氧或硫; R是氢等; Z是氢等; Ar是苯基等; n为1或2,m为1或2,不包括n为2,m为2的化合物。 还提供了包含式[1]化合物或其药学上可接受的盐作为活性成分的药物组合物。 该组合物可用作预防或治疗抑郁症,恐慌症,焦虑症,强迫症,慢性疼痛,纤维肌痛,肥胖,压力性尿失禁和膀胱过动症的药剂。